General MedicationsORALGeneric
FUNGIZONE
AMPHOTERICIN B
Standard Dose
100MG/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview FUNGIZONE is listed in Drugs@FDA under application 050341 (NDA).
Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength SUSPENSION;ORAL - 100MG/ML Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 1997-01-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview FUNGIZONE is listed in Drugs@FDA under application 050341 (NDA). Marketing status: Discontinued Active ingredient AMPHOTERICIN B Form and strength SUSPENSION;ORAL - 100MG/ML Sponsor BRISTOL MYERS SQUIBB Submission history Latest submission status date: 1997-01-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.